Basic Information
Basic information for MIR9-3HG-246-19aa-2
Peptide Name MIR9-3HG-246-19aa-2
Genome Position chr15:89387820-89387876[+]
Species Human
Peptide Sequence MLWSQKTAKREAEAPVARV
Peptide Length 19
Unique No (MIR9-3HG-201-19aa-3,MIR9-3HG-202-19aa-1,MIR9-3HG-203-19aa-1,MIR9-3HG-204-19aa,MIR9-3HG-205-19aa-1,MIR9-3HG-206-19aa,MIR9-3HG-207-19aa,MIR9-3HG-208-19aa,MIR9-3HG-210-19aa,MIR9-3HG-211-19aa,MIR9-3HG-212-19aa-2,MIR9-3HG-213-19aa-2,MIR9-3HG-214-19aa-1,MIR9-3HG-215-19aa,MIR9-3HG-216-19aa,MIR9-3HG-217-19aa,MIR9-3HG-218-19aa-1,MIR9-3HG-219-19aa-1,MIR9-3HG-220-19aa-2,MIR9-3HG-221-19aa-2,MIR9-3HG-222-19aa-1,MIR9-3HG-223-19aa,MIR9-3HG-224-19aa-1,MIR9-3HG-225-19aa-1,MIR9-3HG-226-19aa-1,MIR9-3HG-227-19aa-1,MIR9-3HG-228-19aa-1,MIR9-3HG-229-19aa-1,MIR9-3HG-230-19aa,MIR9-3HG-231-19aa,MIR9-3HG-233-19aa-3,MIR9-3HG-234-19aa,MIR9-3HG-235-19aa,MIR9-3HG-236-19aa,MIR9-3HG-237-19aa,MIR9-3HG-238-19aa,MIR9-3HG-239-19aa,MIR9-3HG-240-19aa-1,MIR9-3HG-241-19aa-1,MIR9-3HG-242-19aa-1,MIR9-3HG-243-19aa,MIR9-3HG-244-19aa-1,MIR9-3HG-245-19aa,MIR9-3HG-247-19aa-2,MIR9-3HG-248-19aa-1,MIR9-3HG-249-19aa-1,MIR9-3HG-250-19aa,MIR9-3HG-251-19aa-1,MIR9-3HG-252-19aa-1,MIR9-3HG-253-19aa-3)
Grand Average of Hydropathicity -0.5263
Relative Molecular Mass 2495.83
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000669098;MIR9-3HG-246
Transcript Length 5427
Coding Ability 0.4728
DNA Sequence Corresponding to Peptide ATGCTCTGGAGTCAGAAGACAGCGAAAAGAGAAGCAGAAGCCCCGGTGGCAAGAGTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :